Paul Reider

No más puestos en curso

Fortuna: 110 877 $ al 31/07/2026

57 años

41 relaciones

Health Technology

Consumer Services

Distribution Services

Perfil

Paul Reider is the founder of Raven Management, LLC, founded in 2013.
Former jobs include Member-Clinical Advisory Board at Tetraphase Pharmaceuticals, Inc., Vice President-Sales & Strategic Accounts at Puma Biotechnology, Inc. from 2019 to 2021, General Manager at Ipsen Biopharmaceuticals Canada, Inc. from 2015 to 2018, Principal at Amgen, Inc., and Chief Commercial Officer at Coherus Oncology, Inc. from 2022 to 2025.
Education includes undergraduate and MBA degrees from Bowling Green State University.

Participaciones conocidas en empresas públicas

Empresa	Fecha	Número de acciones	Valoración	Fecha de valoración
COHERUS ONCOLOGY, INC. 0,05 %	16/04/2026	78.636 ( 0,05 % )	110 877 $	31/07/2026

Antiguos cargos conocidos de Paul Reider.

Empresas	Cargo	Fin
COHERUS ONCOLOGY, INC.	Corporate Officer/Principal	30/04/2025
PUMA BIOTECHNOLOGY, INC.	Ventas & Marketing	01/01/2021
Ipsen Biopharmaceuticals Canada, Inc. Ipsen Biopharmaceuticals Canada, Inc. Medical DistributorsDistribution Services Part of Ipsen SA, Ipsen Biopharmaceuticals Canada, Inc. is a Canadian company that provides information and secure access related to Dysport Therapeutic, a registered trademark product. The company is based in ON. The company's website offers dedicated portals for healthcare professionals and patients, with healthcare professional login secured via IQVIA OneKey web authentication and patient access using an 8-digit drug identification number from their prescription. The company supports Canadian users with reliable information and secure access to Dysport Therapeutic resources.	Corporate Officer/Principal	01/01/2018
TETRAPHASE PHARMACEUTICALS, INC.	Corporate Officer/Principal	-

Ver el detalle de la experiencia de Paul Reider.

Formación de Paul Reider.

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de Paul Reider.

Relaciones

Relaciones de 1er grado

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas privadas	6
Amgen, Inc. Amgen, Inc. BiotechnologyHealth Technology Discovers, develops, manufactures and delivers human therapeutics	Health Technology
Tetraphase Pharmaceuticals, Inc. Tetraphase Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops novel antibiotics	Health Technology
Bowling Green State University Bowling Green State University Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Puma Biotechnology, Inc. Puma Biotechnology, Inc. Pharmaceuticals: MajorHealth Technology Operates as a development stage company which develops biopharmaceuticals used for the treatment of cancer	Health Technology
Coherus BioSciences, Inc. Coherus BioSciences, Inc. Pharmaceuticals: MajorHealth Technology Operates as a commercial-stage biopharmaceutical company that engages in research, development and commercialization of immunotherapies to treat cancer	Health Technology
Ipsen Biopharmaceuticals Canada, Inc. Ipsen Biopharmaceuticals Canada, Inc. Medical DistributorsDistribution Services Part of Ipsen SA, Ipsen Biopharmaceuticals Canada, Inc. is a Canadian company that provides information and secure access related to Dysport Therapeutic, a registered trademark product. The company is based in ON. The company's website offers dedicated portals for healthcare professionals and patients, with healthcare professional login secured via IQVIA OneKey web authentication and patient access using an 8-digit drug identification number from their prescription. The company supports Canadian users with reliable information and secure access to Dysport Therapeutic resources.	Distribution Services